Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time
Ruth B Schneider, Peggy Auinger, Christopher G Tarolli, Julia Iourinets, María Cristina Gil Díaz, Irene H Richard, Ruth B Schneider, Peggy Auinger, Christopher G Tarolli, Julia Iourinets, María Cristina Gil Díaz, Irene H Richard
Abstract
The Parkinson's disease (PD)-specific Parkinson Anxiety Scale (PAS) is an anxiety rating scale that has been validated in cross-sectional studies. In a study of buspirone for anxiety in PD, it appears that the PAS may be sensitive to change in anxiety demonstrating moderate-to-high correlation with participant-reported and clinician-administered scales.
Keywords: Anxiety; Parkinson’s disease; Scale.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
© 2021 The Authors. Published by Elsevier Ltd.
References
- D'Iorio A., Vitale C., Piscopo F., Baiano C., Falanga A.P., Longo K., Amboni M., Barone P., Santangelo G. Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson’s disease. Parkinsonism Relat Disord. 2017;43:114–117.
- Martinez-Martin P., Leentjens A.F.G., de Pedro-Cuesta J., Chaudhuri K.R., Schrag A.E., Weintraub D. Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson’s disease. Mov Disord. 2016;31(3):270–279.
- Leentjens A.F., Dujardin K., Pontone G.M., Starkstein S.E., Weintraub D., Martinez-Martin P. The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale. Mov Disord. 2014;29:1035–1043.
- Schneider R.B., Auinger P., Tarolli C.G., Iourinets J., Gil-Díaz M.C., Richard I.H. A trial of buspirone for anxiety in Parkinson’s disease: Safety and tolerability. Parkinsonism Relat Disord. 2020;81:69–74.
Source: PubMed